These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2165542)

  • 1. [Relationship between ultrasound-findings of low-echoic nodule of hepatic parenchyma in liver cirrhosis and development of hepatocellular carcinoma].
    Mikami N; Ebara M; Yoshikawa M; Ohto M
    Nihon Shokakibyo Gakkai Zasshi; 1990 Apr; 87(4):1010-9. PubMed ID: 2165542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development.
    Benvegnù L; Noventa F; Bernardinello E; Pontisso P; Gatta A; Alberti A
    Gut; 2001 Jan; 48(1):110-5. PubMed ID: 11115831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis.
    Kobayashi M; Ikeda K; Hosaka T; Sezaki H; Someya T; Akuta N; Suzuki F; Suzuki Y; Saitoh S; Arase Y; Kumada H
    Cancer; 2006 Feb; 106(3):636-47. PubMed ID: 16369988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
    Forner A; Vilana R; Ayuso C; Bianchi L; Solé M; Ayuso JR; Boix L; Sala M; Varela M; Llovet JM; Brú C; Bruix J
    Hepatology; 2008 Jan; 47(1):97-104. PubMed ID: 18069697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with ultrasonic coarse-nodular cirrhosis who are anti-hepatitis C virus-positive are at high risk for hepatocellular carcinoma.
    Tarao K; Hoshino H; Shimizu A; Ohkawa S; Harada M; Nakamura Y; Ito Y; Tamai S; Okamoto N
    Cancer; 1995 Mar; 75(6):1255-62. PubMed ID: 7533653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
    Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
    BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance Program for Diagnosis of HCC in Liver Cirrhosis: Role of Ultrasound Echo Patterns.
    Soresi M; Terranova A; Licata A; Serruto A; Montalto G; Brancatelli G; Giannitrapani L
    Biomed Res Int; 2017; 2017():4932759. PubMed ID: 28638828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk lesions in cirrhosis and development of hepatocellular carcinoma: an autopsy study.
    Nakanuma Y; Kanel GC; Doishita K; Ohta G; Peters RL
    Biomed Pharmacother; 1989; 43(2):127-33. PubMed ID: 2544232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis.
    Kim MN; Kim BK; Kim SU; Park JY; Ahn SH; Han KH; Kim DY
    Scand J Gastroenterol; 2019 Oct; 54(10):1283-1290. PubMed ID: 31593481
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
    Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study.
    Caturelli E; Solmi L; Anti M; Fusilli S; Roselli P; Andriulli A; Fornari F; Del Vecchio Blanco C; de Sio I
    Gut; 2004 Sep; 53(9):1356-62. PubMed ID: 15306600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Close association between high serum alanine aminotransferase levels and multicentric hepatocarcinogenesis in patients with hepatitis C virus-associated cirrhosis.
    Tarao K; Rino Y; Ohkawa S; Tamai S; Miyakawa K; Takakura H; Endo O; Yoshitsugu M; Watanabe N; Matsuzaki S
    Cancer; 2002 Mar; 94(6):1787-95. PubMed ID: 11920542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan.
    Chen TH; Chen CJ; Yen MF; Lu SN; Sun CA; Huang GT; Yang PM; Lee HS; Duffy SW
    Int J Cancer; 2002 Mar; 98(2):257-61. PubMed ID: 11857416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of hepatocellular carcinoma among Indian patients with cirrhosis of liver: an experience from a tertiary care center in northern India.
    Paul SB; Sreenivas V; Gulati MS; Madan K; Gupta AK; Mukhopadhyay S; Panda SK; Acharya SK
    Indian J Gastroenterol; 2007; 26(6):274-8. PubMed ID: 18431010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver with hypoechoic nodular pattern as a risk factor for hepatocellular carcinoma.
    Kitamura S; Iishi H; Tatsuta M; Ishikawa H; Hiyama T; Tsukuma H; Kasugai H; Tanaka S; Kitamura T; Ishiguro S
    Gastroenterology; 1995 Jun; 108(6):1778-84. PubMed ID: 7768383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.
    Cho HJ; Kim B; Lee JD; Kang DR; Kim JK; Lee JH; Shin SJ; Lee KM; Yoo BM; Lee KJ; Kim SS; Cheong JY; Cho SW
    Am J Gastroenterol; 2017 Mar; 112(3):460-470. PubMed ID: 27779194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
    Ganne-Carrié N; Chaffaut C; Bourcier V; Archambeaud I; Perarnau JM; Oberti F; Roulot D; Moreno C; Louvet A; Dao T; Moirand R; Goria O; Nguyen-Khac E; Carbonell N; Antonini T; Pol S; de Ledinghen V; Ozenne V; Henrion J; Péron JM; Tran A; Perlemuter G; Amiot X; Zarski JP; Beaugrand M; Chevret S;
    J Hepatol; 2018 Dec; 69(6):1274-1283. PubMed ID: 30092234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
    Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
    AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of dysplastic nodules, early hepatocellular carcinoma and progressed hepatocellular carcinoma in cirrhosis with contrast-enhanced ultrasound.
    Giorgio A; Calisti G; di Sarno A; Farella N; de Stefano G; Scognamiglio U; Giorgio V
    Anticancer Res; 2011 Nov; 31(11):3977-82. PubMed ID: 22110230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.